IGG4 REA FC
OrganismNot specified
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein heterocomplex Heteromer Protein × 3 PDB declaration: trimeric(3) Consistent with protein copy count | Chain A; UniProt 118–323 | Fragment:FC | IGM-LAMBDA RF-AN FAB (LIGHT CHAIN) × 1 IGM-LAMBDA RF-AN FAB (HEAVY CHAIN) × 1 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;pH 7;CRYSTALS WERE GROWN BY HANGING DROP VAPOR DIFFUSION. THE HANGING DROPS CONSISTED OF 2UL OF PROTEIN SOLUTION CONTAINING EACH PROTEIN AT 1MG/ML IN 0.1 % SODIUM AZIDE, 20MM TRIS-HCL AT PH 7.0, MIXED WITH AN EQUAL VOLUME OF THE RESERVOIR SOLUTION TO BE SCREENED. CRYSTALS WERE OBTAINED WITH RESERVOIR SOLUTIONS CONTAINING 17.5 - 22.5 % (W/V) POLYETHYLENE GLYCOL (MEAN MW 8000) IN 0.1 % SODIUM AZIDE, 100MM TRIS-HCL, PH 7.0, AT TEMPERATURES BETWEEN 17.5 AND 21.5 (CELSIUS)., vapor diffusion - hanging drop | Resolution 3.15 Å R-free 0.289 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 1ADQ | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1BBJ CRYSTAL STRUCTURE OF A CHIMERIC FAB' FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS Deposited 1992-04-30 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain H
1–98(98 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 3.10 Å |
| 1BBJ CRYSTAL STRUCTURE OF A CHIMERIC FAB' FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS Deposited 1992-04-30 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1–98(98 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 3.10 Å |
| 4B53 Crystal structure of the isolated IgG4 CH3 domain Deposited 2012-08-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
222–327(106 aa)
Fragment:CH3 DOMAIN, RESIDUES 222-327
Chain B
222–327(106 aa)
Fragment:CH3 DOMAIN, RESIDUES 222-327
|
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) | EDO 1,2-ETHANEDIOL × 5 PEG DI(HYDROXYETHYL)ETHER × 4 TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 ACT ACETATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;SITTING DROP AT 291K. RESERVOIR OF 100 MICROLITRE 22% PEG 3350 AND 150MM CALCIUM ACETATE. DROP SIZE 100 NANOLITRE PROTEIN AND 100 NANOLITRE RESERVOIR. PROTEIN CONCENTRATION OF 1.5MG/ML
|
Resolution 1.80 Å R-free 0.237 |
| 4C54 Crystal structure of recombinant human IgG4 Fc Deposited 2013-09-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
114–327(214 aa)
Fragment:FC FRAGMENT, RESIDUES 114-327
Chain B
114–327(214 aa)
Fragment:FC FRAGMENT, RESIDUES 114-327
|
Not recorded | MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 2 EDO 1,2-ETHANEDIOL × 9 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;MES PH6.5. 18-20% PEG 20 000
|
Resolution 1.90 Å R-free 0.209 |
| 4C55 Crystal structure of serum-derived human IgG4 Fc Deposited 2013-09-10 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
110–327(218 aa)
Fragment:FC FRAGMENT, RESIDUES 110-327
|
Not recorded | MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 EDO 1,2-ETHANEDIOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;MES PH6.5. 18-20% PEG 20 000
|
Resolution 2.35 Å R-free 0.238 |
| 4C55 Crystal structure of serum-derived human IgG4 Fc Deposited 2013-09-10 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
110–327(218 aa)
Fragment:FC FRAGMENT, RESIDUES 110-327
|
Not recorded | MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 EDO 1,2-ETHANEDIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;MES PH6.5. 18-20% PEG 20 000
|
Resolution 2.35 Å R-free 0.238 |
| 4D2N Crystal structure of deglycosylated serum-derived human IgG4 Fc Deposited 2014-05-12 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
102–327(226 aa)
Fragment:FC FRAGMENT, RESIDUES 102-327
Chain D
102–327(226 aa)
Fragment:FC FRAGMENT, RESIDUES 102-327
|
Mutation:YES Mutation:YES | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;291 K;CRYSTALS WERE GROWN AT 291K USING A RESERVOIR OF 100MM BIS-TRIS PROPANE PH7.5, 20% PEG 3350 AND 200MM SODIUM CITRATE, AND A PROTEIN CONCENTRATION OF 6MG/ML.
|
Resolution 2.70 Å R-free 0.254 |
| 4D2N Crystal structure of deglycosylated serum-derived human IgG4 Fc Deposited 2014-05-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
102–327(226 aa)
Fragment:FC FRAGMENT, RESIDUES 102-327
Chain B
102–327(226 aa)
Fragment:FC FRAGMENT, RESIDUES 102-327
|
Mutation:YES Mutation:YES | GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;291 K;CRYSTALS WERE GROWN AT 291K USING A RESERVOIR OF 100MM BIS-TRIS PROPANE PH7.5, 20% PEG 3350 AND 200MM SODIUM CITRATE, AND A PROTEIN CONCENTRATION OF 6MG/ML.
|
Resolution 2.70 Å R-free 0.254 |
| 5HVW Monomeric IgG4 Fc Deposited 2016-01-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
115–324(210 aa)
|
Mutation:L351F, T366R, P395K, F405R, Y407E | ZN ZINC ION × 12 GOL GLYCEROL × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;9 mM ZnCl2, 90 mM Hepes, pH 7.0, 18% PEG 6000 (w/v)
|
Resolution 1.95 Å R-free 0.258 |
| 5HVW Monomeric IgG4 Fc Deposited 2016-01-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
115–324(210 aa)
|
Mutation:L351F, T366R, P395K, F405R, Y407E | ZN ZINC ION × 2 GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;9 mM ZnCl2, 90 mM Hepes, pH 7.0, 18% PEG 6000 (w/v)
|
Resolution 1.95 Å R-free 0.258 |
| 5LG1 Room temperature structure of human IgG4-Fc from crystals analysed in situ Deposited 2016-07-05 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
114–327(214 aa)
Chain B
114–327(214 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;291 K;0.1M MES, 18-20% PEG 20 000
|
Resolution 2.70 Å R-free 0.231 |
| 5W5M Crystal structure of human IgG4-Sigma1 Fc fragment Deposited 2017-06-15 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
106–327(222 aa)
Fragment:Sigma1 Fc fragment, UNP residues 106-327
Chain B
106–327(222 aa)
Fragment:Sigma1 Fc fragment, UNP residues 106-327
|
Not recorded | GOL GLYCEROL × 2 ACT ACETATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;9% (w/v) PEG 20K, 0.1 M sodium acetate, pH 5.5
|
Resolution 1.90 Å R-free 0.225 |
| 5W5N Crystal structure of human IgG4-Sigma2 Fc fragment Deposited 2017-06-15 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
106–327(222 aa)
Fragment:Sigma2 Fc fragment, UNP residues 106-327
Chain B
106–327(222 aa)
Fragment:Sigma2 Fc fragment, UNP residues 106-327
|
Not recorded | GOL GLYCEROL × 2 ACT ACETATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;10% (w/v) PEG 20K, 0.1 M sodium acetate, 5.5, 5% (v/v) MPD
|
Resolution 1.85 Å R-free 0.215 |
| 6WIB Next generation monomeric IgG4 Fc Deposited 2020-04-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
115–325(211 aa)
|
Mutation:L351F, T366R, P395K, F405R, Y407e, L432C, H433S, N434W, Y436L, T437C, Q438 deleted | ZN ZINC ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.5;298 K;0.01 M zinc sulfate heptahydrate; 0.1 M morpholineethanesulfonic acid (MES) monohydrate, pH 6.5, and 25% (w/v) PEG 550 MME at a protein concentration of 5.5 mg/mL
|
Resolution 2.55 Å R-free 0.266 |
| 6WMH Next generation monomeric IgG4 Fc Deposited 2020-04-21 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain H
118–324(207 aa)
Fragment:domains Ch2 and Ch3
|
Mutation:M252Y, S254T, T256E, N297D, L351F, S354E, T366R, P395K, F405R, Y407E | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;295 K;DL-Glutamic acid monohydrate,
DL-Alanine,
Glycine,
DL-Lysine monohydrochloride,
DL-Serine,
Sodium HEPES, MOPS (acid),
Ethylene glycol,
PEG 8000
|
Resolution 2.30 Å R-free 0.243 |
| 6WMH Next generation monomeric IgG4 Fc Deposited 2020-04-21 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
118–324(207 aa)
Fragment:domains Ch2 and Ch3
|
Mutation:M252Y, S254T, T256E, N297D, L351F, S354E, T366R, P395K, F405R, Y407E | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;295 K;DL-Glutamic acid monohydrate,
DL-Alanine,
Glycine,
DL-Lysine monohydrochloride,
DL-Serine,
Sodium HEPES, MOPS (acid),
Ethylene glycol,
PEG 8000
|
Resolution 2.30 Å R-free 0.243 |
| 6WNA Next generation monomeric IgG4 Fc Deposited 2020-04-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain H
118–324(207 aa)
Fragment:domains Ch2 and Ch3
|
Mutation:M252Y, S254T, T256E, L351F, S354E, T366R, P395K, F405R, Y407E, | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;295 K;0.2 M magnesium chloride hexahydrate, 30% 1,5-diaminopentane dihydrochloride, 0.1 M MES, pH 6 and 20% PEG 6000 at a protein concentration of 6 mg/mL
|
Resolution 2.40 Å R-free 0.263 |
| 6WOL Next generation monomeric IgG4 Fc bound to neonatal Fc receptor Deposited 2020-04-24 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain H
117–326(210 aa)
Fragment:domains Ch3 and Ch4
|
Mutation:L351F, S354E, T366R, P395K, F405R, Y407E, L432C, H433S, N434Y, Y436L, T437C, Q438 deleted | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6;295 K;0.2 M magnesium chloride hexahydrate, 1 M sodium iodide, 0.1 M MES, pH 6 and 20% PEG 6000 at a protein concentration of 6.35 mg/mL
|
Resolution 2.49 Å R-free 0.270 |
13 other PDB entries and 18 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | IGHG4_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–206; UniProt 118–323 |